The Inpatient Burden of Pediatric Dermatology in the United States: A National Analysis of the 2022 Kids' Inpatient Database
Pediatric Dermatology · 2026
DOI: 10.1111/pde.70151 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Dermatology, 2026. Verfasst von Shiv Patel und 3 weiteren Autor:innen. Beteiligte Einrichtung: Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA. Hauptthemen laut MEDLINE: Hospitalization, Skin Diseases, Dermatology. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Dermatologic conditions are a significant reason for pediatric hospitalizations in the United States. A prior analysis of the 2012 Kids' Inpatient Database (KID) established a national benchmark for this burden, but changes in medical coding, healthcare delivery, and demographics necessitate an updated assessment. This study aimed to quantify the current inpatient burden of pediatric dermatology and to identify associated demographic risk factors, financial costs, and mortality using a recent, nationally representative database.
Methods
A cross‐sectional study was conducted using the 2022 KID. Pediatric hospitalizations with a primary dermatology diagnosis (ICD‐10‐CM) were identified. Survey weights were used to generate national estimates of admission counts, costs, and mortality. Multivariable logistic regression was used to identify independent risk factors for a primary dermatology hospitalization.
Results
In 2022, there were an estimated 29,766 pediatric dermatology hospitalizations, representing 2.3% of all pediatric admissions and a decline from 4.2% in 2012. These admissions generated a total national cost of $449.3 million. After adjusting for covariates, factors associated with higher odds of a dermatology admission included age 2–5 years (OR: 1.35; 95% CI: 1.21–1.52), Asian/Pacific Islander race (OR: 1.49; 95% CI: 1.32–1.69), Native American race (OR: 1.17; 95% CI: 1.00–1.36), Hispanic ethnicity (OR: 1.07; 95% CI: 1.01–1.14), lowest income quartile (OR: 1.06; 95% CI: 1.01–1.12), and Medicaid coverage (OR: 1.09; 95% CI: 1.04–1.14). Female sex was associated with lower odds (OR: 0.95; 95% CI: 0.92–0.98). In‐hospital mortality was 0.1%.
Conclusion
The national burden of inpatient pediatric dermatology has decreased over the past decade. However, significant disparities related to socioeconomic status and race/ethnicity persist and have evolved. These findings underscore the continued need for interventions aimed at improving access to outpatient dermatologic care for underserved pediatric populations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
- University of Florida, Gainesville, Florida, USA.
- School of Medicine and Public Health, University of Wisconsin, Madison, Wisconsin, USA.
ORCID-Profile: Shiv Patel, Aayush Shah, Vibhusha Kolli, Peter A Lio
Zitieren
APA
Patel, S., Shah, A., Kolli, V., & Lio, P. A. (2026). The Inpatient Burden of Pediatric Dermatology in the United States: A National Analysis of the 2022 Kids' Inpatient Database. Pediatric Dermatology. https://doi.org/10.1111/pde.70151
Vancouver
Patel S, Shah A, Kolli V, Lio PA. The Inpatient Burden of Pediatric Dermatology in the United States: A National Analysis of the 2022 Kids' Inpatient Database. Pediatric Dermatology. 2026. doi:10.1111/pde.70151
BibTeX
@article{Patel2026,
author = {Patel, Shiv and Shah, Aayush and Kolli, Vibhusha and Lio, Peter A},
title = {The Inpatient Burden of Pediatric Dermatology in the United States: A National Analysis of the 2022 Kids' Inpatient Database},
journal = {Pediatric Dermatology},
year = {2026},
doi = {10.1111/pde.70151}
}
EUVIMED